Safety and efficacy of angiotensin II receptor antagonists

被引:0
|
作者
Neutel, JM [1 ]
机构
[1] Orange Cty Heart Inst, Orange, CA 92668 USA
[2] Res Ctr, Orange, CA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 84卷 / 2A期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A disturbing pattern in the management of hypertension is emerging worldwide. More patients are being treated for hypertension, but blood pressures are not decreasing to target levels. Inadequate reduction in blood pressure is a risk factor for coronary artery disease. Poor drug efficacy, side effects, and lack of compliance are important factors leading to inadequate control of blood pressure. Angiotensin II receptor antagonists provide adequate 24-hour blood pressure control, as measured by ambulatory blood pressure monitoring, and have a side-effect profile similar to placebo. They also provide better patient compliance through once-daily dosing. This article compares the safety and efficacy of angiotensin II receptor antagonists with other antihypertensive agents. (C) 1999 by Excerpta Medica, Inc.
引用
收藏
页码:13K / 17K
页数:5
相关论文
共 50 条
  • [21] Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes
    Winkelmayer, Wolfgang C.
    Zhang, Zhongxin
    Shahinfar, Shahnaz
    Cooper, Mark E.
    Avorn, Jerry
    Brenner, Barry M.
    DIABETES CARE, 2006, 29 (10) : 2210 - 2217
  • [22] Angiotensin II receptor antagonists: Candesartan cilexetil
    Naka, T
    Kubo, K
    Nishikawa, K
    Inada, Y
    Furukawa, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (12): : 1261 - 1275
  • [23] Dual Angiotensin II and Endothelin Receptor Antagonists
    Palaniswamy, Chandrasekar
    Selvaraj, Dhana R.
    Palaniappan, Dhamodaran
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (03) : E67 - E70
  • [24] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    TIMMERMANS, PBMWM
    CARINI, DJ
    CHIU, AT
    DUNCIA, JV
    PRICE, WA
    WELLS, GJ
    WONG, PC
    WEXLER, RR
    JOHNSON, AL
    AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (08) : 599 - 604
  • [25] Overview of angiotensin II-receptor antagonists
    Pitt, B
    Konstam, MA
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (10A): : 47S - 49S
  • [26] Metabolic syndrome and angiotensin II receptor antagonists
    Mamyrbayeva, K. M.
    Mychka, V. B.
    Sergienko, V. B.
    Chazova, L. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (02): : 42 - +
  • [27] Antagonists of the AT1 receptor for angiotensin II
    Kawecka-Jaszcz, Kalina
    Czarnecka, Danuta
    Wojciechowska, Wiktoria
    ARTERIAL HYPERTENSION, 2006, 10 : A1 - A15
  • [28] Angiotensin II receptor antagonists for heart failure
    Struthers, AD
    HEART, 1998, 80 (01) : 5 - 6
  • [29] Angiotensin II receptor antagonists: The prototype losartan
    Schaefer, KL
    Porter, JA
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) : 625 - 636
  • [30] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    TIMMERMANS, PBMWM
    WONG, PC
    CHIU, AT
    HERBLIN, WF
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (02) : 55 - 62